HUMAN MONOCLONAL ANTIBODIES THAT TARGET TERMINAL ALPHA-GAL MOIETIES ON VECTOR-BORNE PATHOGENS AND UNRESECTABLE SOLID TUMORS
Technology
E-193-2022
Patent ID
E-193-2022-0-US-01
Country
US
Application Type
Patent Status
Expired
Patent Number
Publication Number
Application Number
63/647,859
IC
NIAID
Date Filed
Date Issued
Patent PDF